BLINCYTO J Code: J9039

Drug & Product Overview

HCPCS Descriptor Injection, blinatumomab, 1 microgram

HCPCS Added Date January 1, 2016

Manufacturer Amgen

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Kit

About BLINCYTO

Blincyto is a medication aligned to the HCPCS J Code: J9039 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by Amgen.

According to CMS Drug Use Information: This medication is used to treat a certain type of cancer (acute lymphoblastic leukemia-ALL). Blinatumomab belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 2 of 3 NDCs — log in for the full crosswalk.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
55513-0160-01	Blincyto	Amgen, Inc	35	Kit
55513-0160-21	Blincyto	Amgen, Inc	35	Kit
•••••-••••-•• Log in to view	BLINCYTO

Login to view 1 more NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

BLINCYTO Pricing & Reimbursement

J9039 Private Payer Reimbursement

$169.84 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

BLINCYTO Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 19.61%

Avg. Days to File 11.0days

Avg. Days to Pay 29.7days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9039 claims analytics on FocalPoint →

BLINCYTO CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

JW / JZ modifiers apply

CMS has identified Blincyto (J9039) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

BLINCYTO Medically Unlikely Edits (MUE)

The most billing units of J9039 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mcg.

Practitioner Office & Hospital Outpatient

210 units / day

= 210 mcg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

BLINCYTO Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

B-cell Precursor ALL in the Consolidation Phase MRD-positive B-cell Precursor ALL Relapsed or Refractory B-cell Precursor ALL

Frequently Asked Questions

Is there an available Blincyto billing and coding guide?

Billing and coding information for BLINCYTO can be found through Amgen. Visit Here →

Are there any available Blincyto patient assistance programs?

BLINCYTO patient assistance information can be found through Amgen. Visit Here →

Where can I find Blincyto prescribing information?

BLINCYTO prescribing information can be found at the link below: Visit Here →

Where can I find Blincyto side effect information?

Information regarding BLINCYTO's side effects can be found at MedlinePlus Visit Here →

Does billing BLINCYTO require JZ/JW wastage modifiers?

CMS has identified BLINCYTO(J9039) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.